Falciparum malaria resistant to chloroquine and Fansidar. 1984

M Jaatinen, and C M Kihamia, and D G McLarty

UI MeSH Term Description Entries
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011739 Pyrimethamine One of the FOLIC ACID ANTAGONISTS that is used as an antimalarial or with a sulfonamide to treat toxoplasmosis. Chloridin,Daraprim,Malocide,Tindurine
D002738 Chloroquine The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses. Aralen,Arechine,Arequin,Chingamin,Chlorochin,Chloroquine Sulfate,Chloroquine Sulphate,Khingamin,Nivaquine,Sulfate, Chloroquine,Sulphate, Chloroquine
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013413 Sulfadoxine A long acting sulfonamide that is used, usually in combination with other drugs, for respiratory, urinary tract, and malarial infections. Sulformethoxine,Sulforthomidine,Fanasil,Ro 4-4393,Sulformetoxine,Sulphormetoxin,Sulphorthodimethoxine,Ro 4 4393,Ro 44393
D013424 Sulfanilamides Compounds based on 4-aminobenzenesulfonamide. The '-anil-' part of the name refers to aniline. Sulphanilamides

Related Publications

M Jaatinen, and C M Kihamia, and D G McLarty
February 1984, British medical journal (Clinical research ed.),
M Jaatinen, and C M Kihamia, and D G McLarty
October 1983, British medical journal (Clinical research ed.),
M Jaatinen, and C M Kihamia, and D G McLarty
August 1983, Revista de saude publica,
M Jaatinen, and C M Kihamia, and D G McLarty
March 1983, The American journal of tropical medicine and hygiene,
M Jaatinen, and C M Kihamia, and D G McLarty
September 1979, Lancet (London, England),
M Jaatinen, and C M Kihamia, and D G McLarty
March 1985, Lancet (London, England),
M Jaatinen, and C M Kihamia, and D G McLarty
January 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene,
M Jaatinen, and C M Kihamia, and D G McLarty
March 1983, The New England journal of medicine,
M Jaatinen, and C M Kihamia, and D G McLarty
November 1968, Lancet (London, England),
M Jaatinen, and C M Kihamia, and D G McLarty
May 1980, The Medical journal of Australia,
Copied contents to your clipboard!